Author Archives: Lindsey Womack

The second annual Community Health Impact Awards (CHIA), held on October 23, celebrated individuals and teams across UNC Health and the UNC School of Medicine who are transforming care and strengthening communities in North Carolina. Several members of the UNC Department of Neurology were recognized for their outstanding contributions: Dr....

The UNC Department of Neurology proudly congratulates Dr. Deanna Saylor on receiving the Osuntokun Award at the 5th Annual African Stroke Organization (ASO) Conference, held November 3–5, 2025, at the Sarova Panafric Hotel in Nairobi, Kenya. Dr. Deanna Saylor serves as an Associate Professor of Neurology and is a member...

We are proud to announce that the University of North Carolina ALS Clinic has officially been designated as an ALS Association Certified Treatment Center of Excellence! This recognition reflects the clinic’s commitment to providing outstanding, compassionate, and multidisciplinary care to individuals living with ALS and their families. The designation was...

A new clinic will bring ALS care to support the unique needs of individuals living in rural North Carolina. UNC Health Pardee has expanded its neurological services with the opening of a dedicated Amyotrophic Lateral Sclerosis (ALS) Clinic, the first multidisciplinary clinic of its kind in the region.

Chapel Hill, N.C. — A team at the UNC Center for Animal Magnetic Resonance Imaging (CAMRI) has published a pioneering protocol that outlines how to integrate electrochemical brain recordings with MRI imaging—a breakthrough that could transform neuroscience research and clinical applications. CAMRI is part of BRIC’s service core and provides...

We are using specialized functional MRI for people receiving deep brain stimulation surgery to help predict who will benefit most from this procedure.

BioBOOST is a multicenter, observational study of the effect of derangements in brain physiologic parameters on brain injury biomarker levels in patients with severe traumatic brain injury. Detailed Description Traumatic brain injury (TBI) remains a major cause of death and disability, with an estimated cost of $45 billion/year in the...

This is a genetic registry study aimed at developing a central location to store Parkinson’s Disease genetic data for future research use.

Open-label Uncontrolled Trial to Evaluate Pharmacokinetics, Pharmacodynamics, Safety, and Activity of Efgartigimod in Children From 2 to Less Than 18 Years of Age With Generalized Myasthenia Gravis- ARGX-113-2006. For more information or to register for the study, contact Study Coordinator Manisha Chopra

This study aims to investigate whether multiple sclerosis patients who haven’t had a relapse within the past year would benefit from switching to ofatumumab VS. continuing their current therapy, based on measures of disease activity, and a baseline neurofilament light level. Neurofilament is a marker of nerve cell loss in...